Robert Nmn Cain Jr., PA, PhD

Robert Cain practices at University of Florida Jacksonville Physicians, Inc. in Jacksonville, Florida.

Robert Cain's NPI, 1952569303, was assigned on June 1, 2008. Robert Cain holds Florida license PA911169.

Robert Cain's primary practice is University of Florida Jacksonville Physicians, Inc., at 653 8th W St, Jacksonville, FL 32209 in Duval County. The practice phone is (904) 244-3500.

Robert Cain's primary practice is University of Florida Jacksonville Physicians, Inc. in Jacksonville, Florida. Robert Cain is also affiliated with UF Health Jacksonville. The medical group on file is UF Jacksonville Physicians, Inc. Dmand AI also links Robert Cain to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Robert Cain practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Robert Cain's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Robert Cain is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Robert Cain is licensed in Florida.

Dmand AI lists arthritis, asthma, broken or dislocated ankle/ or foot, bronchitis, chronic obstructive pulmonary disease (COPD), contact dermatitis, diabetic emergency and ear eustachian tube disorders among the conditions Robert Cain treats.

CMS data shows 55 Medicare services from Robert Cain across 2 procedure codes in 2024, for 31 Medicare patients. Medicare paid $2,305 for them. Every service was in an office.

CMS counts 31 Medicare patients who saw Robert Cain in 2024. The largest group is 75 to 84, with 11 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Robert Cain's median patient age at 51, with 61% women.

In 2024, Robert Cain wrote 1,316 Medicare Part D claims for 156 patients. 88% of them were for generic drugs. CMS names the drug for 932 of them, across 36 drugs with 11 or more claims each, at $39,473 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 60 out of 100 for Robert Cain for performance year 2024, reported through an alternative payment model (APM). Robert Cain accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Robert Cain as offering telehealth.

CMS Open Payments shows 5 general payments to Robert Cain from 5 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $145.